Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nominations To Lead FDA Coming Soon For Hamburg And Sharfstein

This article was originally published in The Rose Sheet

Executive Summary

The White House is set to nominate former New York City Health Commissioner Margaret Hamburg as FDA commissioner, according to sources knowledgeable about the selection process

You may also be interested in...



Hamburg Joins Sharfstein On FDA Commissioner Shortlist

The removal of Duke University cardiologist Robert Califf's name from consideration for FDA commissioner indicates that a record of government service and a strong public health background will trump all other qualifications for the post

Obama Wants FDA’s “Full Review” As Recall Of Peanut Butter Items Goes On

FDA is due for a "full review" in light of a salmonella outbreak that has sickened more than 500 people, possibly killed eight, and prompted a massive recall of peanut butter products, according to President Obama

US Medicare Plans 'Can' Cover Wegovy, CMS Says, But Will They?

Medicare is making clear that Part D ‘can’ cover GLP-1 inhibitors that are approved for cardiovascular indications – but in language that seems to leave plans considerable discretion for now. The formulary review process for 2025 may be a more important milestone for changes.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016009

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel